All ProductsDisplaying Products by Catalog Number (1900 - 1999)
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300
| Cat. No. | Product Name / Activity |
|---|---|
| 1900 | [Ala107]-MBP (104-118) |
| Protein kinase C inhibitor | |
| 1901 | [Ala113]-MBP (104-118) |
| Protein kinase C inhibitor | |
| 1902 | [Ala92]-p16 (84-103) |
| Cdk inhibitor | |
| 1904 | PKA inhibitor fragment (6-22) amide |
| Potent protein kinase A inhibitor | |
| 1905 | VIP (6-28) (human, rat, porcine, bovine) |
| VIP receptor antagonist | |
| 1906 | Atrial natriuretic factor (1-28) (human, porcine) |
| Endogenous peptide regulating blood pressure | |
| 1907 | Neuromedin N (rat, mouse, porcine, canine) |
| Neurotensin-like peptide | |
| 1908 | Neuromedin B (porcine) |
| Mammalian bombesin-like peptide | |
| 1909 | Neurotensin |
| Endogenous neurotransmitter and endocrine modulator | |
| 1910 | Oxytocin |
| Involved in uterine contraction and lactation | |
| 1911 | VIP (human, rat, mouse, rabbit, canine, porcine) |
| Involved in neurotransmission and smooth muscle relaxation | |
| 1912 | Atrial natriuretic factor (1-28) (rat) |
| Endogenous peptide regulating blood pressure | |
| 1914 | Eledoisin |
| Potent tachykinin receptor ligand | |
| 1915 | Kinetensin (human) |
| Neurotensin-like peptide | |
| 1916 | Litorin |
| Amphibian bombesin-like peptide | |
| 1918 | Secretin (human) |
| Gastrointestinal peptide | |
| 1919 | Secretin (rat) |
| Gastrointestinal peptide | |
| 1920 | Eledoisin-Related Peptide |
| Tachykinin receptor ligand | |
| 1921 | N-Formyl-Met-Leu-Phe |
| Endogenous FPR1 agonist | |
| 1922 | [D-Lys3]-GHRP-6 |
| Ghrelin receptor antagonist | |
| 1923 | pp60 c-src (521-533) (phosphorylated) |
| Inhibits tyrosine kinase activity of pp60c-src and pp60v-src | |
| 1927 | N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu |
| Phosphopeptide ligand for src SH2 domain | |
| 1928 | Neuropeptide AF (human) |
| Endogenous NPFF1 and NPFF2 agonist; antiopioid neuropeptide and MRGPRA agonist | |
| 1929 | Melanocyte-stimulating hormone release inhibiting factor |
| Inhibitor of α-MSH release; inhibits opioid effects in vivo | |
| 1930 | N-Acetyl-O-phosphono-Tyr-Glu Dipentylamide |
| Phosphopeptide ligand for src SH2 domain | |
| 1931 | G-Protein antagonist peptide |
| Inhibits G protein activation by GPCRs | |
| 1932 | U 46619 |
| Potent, stable thromboxane A2 (TP) receptor agonist | |
| 1933 | Exendin-4 |
| Potent GLP-1 receptor agonist | |
| 1935 | Caffeic acid-pYEEIE |
| Phosphopeptide ligand for src SH2 domain | |
| 1936 | Damnacanthal |
| Potent, selective p56lck inhibitor; also LIMK1/2 inhibitor | |
| 1938 | Amyloid β-Peptide (1-43) (human) |
| Amyloid β-protein fragment | |
| 1939 | C14TKL-1 |
| Endogenous NK1 agonist | |
| 1941 | m-3M3FBS |
| Phospholipase C activator | |
| 1942 | o-3M3FBS |
| Inactive analog of m-3M3FBS (Cat. No. 1941) | |
| 1944 | Loratidine |
| Peripheral H1 antagonist; antiallergic agent | |
| 1946 | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P |
| Potent ghrelin receptor inverse agonist; Antagonist at other neuropeptide receptors | |
| 1947 | PR 39 (porcine) |
| IκBα inhibitor | |
| 1949 | L-670,596 |
| Potent, selective thromboxane A2/prostaglandin endoperoxide antagonist | |
| 1950 | Gap 26 |
| Gap junction blocker; inhibits smooth muscle contraction and IP3-mediated ATP release | |
| 1954 | Antagonist G |
| Broad spectrum neuropeptide receptor antagonist | |
| 1955 | Ritanserin |
| Potent 5-HT2 antagonist | |
| 1956 | Bestatin |
| Aminopeptidase inhibitor | |
| 1960 | SB 334867 |
| Selective non-peptide OX1 antagonist | |
| 1961 | SB 258585 hydrochloride |
| Potent, selective 5-HT6 antagonist | |
| 1962 | SB 239063 |
| Potent, selective p38 MAPK inhibitor; orally active | |
| 1963 | SB 408124 |
| Selective non-peptide OX1 antagonist | |
| 1964 | Gossypol |
| Proapoptotic; downregulates Bcl-2 and Bcl-XL | |
| 1965 | Simvastatin |
| HMG-CoA reductase inhibitor | |
| 1966 | UCM 707 |
| Potent anandamide transport inhibitor | |
| 1967 | Ranitidine hydrochloride |
| Selective H2 antagonist | |
| 1968 | AS 19 |
| Potent 5-HT7 agonist | |
| 1969 | SL 327 |
| Selective inhibitor of MEK1 and MEK2; brain penetrant | |
| 1970 | Norketamine hydrochloride |
| Potent non-competitive NMDA antagonist; antinociceptive | |
| 1971 | (+)-Anabasine hydrochloride |
| High affinity nAChR partial agonist | |
| 1972 | Tianeptine sodium salt |
| Selective facilitator of 5-HT uptake; antidepressant | |
| 1974 | SANT-1 |
| Inhibitor of hedgehog (Hh) signaling; antagonizes smoothened activity | |
| 1979 | L-803,087 trifluoroacetate |
| Potent and selective sst4 agonist | |
| 1980 | L-817,818 |
| Potent and selective sst5 agonist | |
| 1982 | Reboxetine mesylate |
| Potent and selective noradrenalin uptake inhibitor; orally active | |
| 1983 | 740 Y-P |
| Cell-permeable PI 3-kinase activator | |
| 1984 | Nogo-66 (1-40) |
| Competitive antagonist for Nogo-66 receptor; promotes neuron regeneration | |
| 1985 | PNU 142633 |
| Highly selective 5-HT1D agonist | |
| 1987 | Leptomycin B |
| Inhibits nuclear export of proteins; antitumor | |
| 1989 | c-JUN peptide |
| Peptide inhibitor of JNK/c-Jun interaction | |
| 1990 | (R,R)-THC |
| Potent subtype-selective ligand; ERα agonist/ERβ antagonist | |
| 1991 | MPP dihydrochloride |
| Highly selective ERα antagonist | |
| 1992 | Nomifensine |
| Potent noradrenalin and dopamine uptake inhibitor. Antidepressant | |
| 1993 | Halofuginone hydrobromide |
| High affinity competitive prolyl-tRNA synthetase inhibitor | |
| 1994 | ZK 93423 hydrochloride |
| Potent benzodiazepine agonist | |
| 1996 | ZK 93426 hydrochloride |
| Potent and competitive benzodiazepine antagonist | |
| 1997 | Ro 15-4513 |
| Benzodiazepine partial inverse agonist | |
| 1998 | JMV 449 |
| Potent neurotensin receptor agonist | |
| 1999 | Linopirdine dihydrochloride |
| KV7 (KCNQ) channel blocker |